Phase II Iressa Versus Vinorelbine (INVITE)

Status Completed

Clinical Trial Summary

This is a randomized, open label, parallel group, multi-centre, phase II study of progression free survival, comparing oral ZD1839 (IRESSA™) (250 mg tablet once daily) to vinorelbine 30 mg/m2 infusion on days 1 and 8 of a 21-day cycle) in chemonaïve, elderly patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00256711
Study type	Interventional
Source	AstraZeneca
Contact
Status	Completed
Phase	Phase 2
Start date	July 2004
Completion date	February 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00985855` - Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer	Phase 2
Completed	`NCT01048645` - Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer	Phase 2
Completed	`NCT00129844` - Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer	Phase 2
Completed	`NCT00098085` - Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer	Phase 2
Active, not recruiting	`NCT04995523` - A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC	Phase 1/Phase 2
Completed	`NCT00910676` - Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors	Phase 2
Withdrawn	`NCT00108186` - Celecoxib Treatment for Lung Cancer	Phase 1
Recruiting	`NCT05037825` - The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Recruiting	`NCT00379717` - Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)	Phase 1/Phase 2
Completed	`NCT00404924` - ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures	Phase 3
Completed	`NCT00102505` - A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)	Phase 1
Recruiting	`NCT02905591` - A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC	Phase 2
Active, not recruiting	`NCT03088540` - Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)	Phase 3
Terminated	`NCT00232206` - Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer	Phase 2
Terminated	`NCT00271323` - Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients	Phase 2
Completed	`NCT00037817` - Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies	Phase 1
Completed	`NCT03444766` - Study of Nivolumab for Advanced Cancers in India	Phase 4
Completed	`NCT04351334` - Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns
Active, not recruiting	`NCT02416739` - Anticancer Activity of Nicotinamide on Lung Cancer	Phase 2/Phase 3
Completed	`NCT00444015` - Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)	Phase 1